120 related articles for article (PubMed ID: 20738899)
1. Is there a role for surgery in stage IIIA-N2 non-small cell lung cancer?
VAN Schil PE; Waele MD; Hendrik JM; Lauwers PR
Zhongguo Fei Ai Za Zhi; 2008 Oct; 11(5):615-21. PubMed ID: 20738899
[TBL] [Abstract][Full Text] [Related]
2. [Stage III NSCLC. The surgeon's role in exploration and treatment].
van Schil P; de Waele M; Hendriks J; Lauwers P
Rev Mal Respir; 2008 Oct; 25(8 Pt 2):3S88-94. PubMed ID: 18971831
[TBL] [Abstract][Full Text] [Related]
3. A second mediastinoscopy: how to decide and how to do it?
Van Schil PE; De Waele M
Eur J Cardiothorac Surg; 2008 Apr; 33(4):703-6. PubMed ID: 18258447
[TBL] [Abstract][Full Text] [Related]
4. Surgical multimodality treatment for baseline resectable stage IIIA-N2 non-small cell lung cancer. Degree of mediastinal lymph node involvement and impact on survival.
Decaluwé H; De Leyn P; Vansteenkiste J; Dooms C; Van Raemdonck D; Nafteux P; Coosemans W; Lerut T
Eur J Cardiothorac Surg; 2009 Sep; 36(3):433-9. PubMed ID: 19502079
[TBL] [Abstract][Full Text] [Related]
5. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer.
van Meerbeeck JP; Kramer GW; Van Schil PE; Legrand C; Smit EF; Schramel F; Tjan-Heijnen VC; Biesma B; Debruyne C; van Zandwijk N; Splinter TA; Giaccone G;
J Natl Cancer Inst; 2007 Mar; 99(6):442-50. PubMed ID: 17374834
[TBL] [Abstract][Full Text] [Related]
6. Remediastinoscopy in restaging of lung cancer after induction therapy.
Marra A; Hillejan L; Fechner S; Stamatis G
J Thorac Cardiovasc Surg; 2008 Apr; 135(4):843-9. PubMed ID: 18374765
[TBL] [Abstract][Full Text] [Related]
7. Nodal status at repeat mediastinoscopy determines survival in non-small cell lung cancer with mediastinal nodal involvement, treated by induction therapy.
De Waele M; Hendriks J; Lauwers P; Ortmanns P; Vanroelen W; Morel AM; Germonpré P; Van Schil P
Eur J Cardiothorac Surg; 2006 Feb; 29(2):240-3. PubMed ID: 16386916
[TBL] [Abstract][Full Text] [Related]
8. Remediastinoscopy.
Van Schil P; De Waele M; Hendriks J; Lauwers P
J Thorac Oncol; 2007 Apr; 2(4):365-6. PubMed ID: 17409813
[TBL] [Abstract][Full Text] [Related]
9. Phase II trial of a trimodality regimen for stage III non-small-cell lung cancer using chemotherapy as induction treatment with concurrent hyperfractionated chemoradiation with carboplatin and paclitaxel followed by subsequent resection: a single-center study.
Friedel G; Budach W; Dippon J; Spengler W; Eschmann SM; Pfannenberg C; Al-Kamash F; Walles T; Aebert H; Kyriss T; Veit S; Kimmich M; Bamberg M; Kohlhaeufl M; Steger V; Hehr T
J Clin Oncol; 2010 Feb; 28(6):942-8. PubMed ID: 20100967
[TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant therapy for resectable non-small cell lung cancer with mediastinal lymph node involvement.
Tieu BH; Sanborn RE; Thomas CR
Thorac Surg Clin; 2008 Nov; 18(4):403-15. PubMed ID: 19086609
[TBL] [Abstract][Full Text] [Related]
11. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
[TBL] [Abstract][Full Text] [Related]
12. Repeat mediastinoscopy in all its indications: experience with 96 patients and 101 procedures.
Call S; Rami-Porta R; Obiols C; Serra-Mitjans M; Gonzalez-Pont G; Bastús-Piulats R; Quintana S; Belda-Sanchis J
Eur J Cardiothorac Surg; 2011 Jun; 39(6):1022-7. PubMed ID: 21112217
[TBL] [Abstract][Full Text] [Related]
13. The present status of surgery for lung cancer.
Lacquet LK
Acta Chir Belg; 1996; 96(6):245-51. PubMed ID: 9008764
[TBL] [Abstract][Full Text] [Related]
14. Results of trimodality therapy in patients with stage IIIA (N2-bulky) and stage IIIB non-small-cell lung cancer.
Li J; Dai CH; Yu LC; Chen P; Li XQ; Shi SB; Wu JR
Clin Lung Cancer; 2009 Sep; 10(5):353-9. PubMed ID: 19808194
[TBL] [Abstract][Full Text] [Related]
15. Accuracy and survival of repeat mediastinoscopy after induction therapy for non-small cell lung cancer in a combined series of 104 patients.
De Waele M; Serra-Mitjans M; Hendriks J; Lauwers P; Belda-Sanchis J; Van Schil P; Rami-Porta R
Eur J Cardiothorac Surg; 2008 May; 33(5):824-8. PubMed ID: 18342528
[TBL] [Abstract][Full Text] [Related]
16. The role of surgery in N2 non-small cell lung cancer.
DeCamp MM; Ashiku S; Thurer R
Clin Cancer Res; 2005 Jul; 11(13 Pt 2):5033s-5037s. PubMed ID: 16000610
[TBL] [Abstract][Full Text] [Related]
17. Comparison of neoadjuvant cisplatin-based chemotherapy versus radiochemotherapy followed by resection for stage III (N2) NSCLC.
Pezzetta E; Stupp R; Zouhair A; Guillou L; Taffé P; von Briel C; Krueger T; Ris HB
Eur J Cardiothorac Surg; 2005 Jun; 27(6):1092-8. PubMed ID: 15896624
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a treatment strategy for optimising preoperative chemoradiotherapy in stage III non-small-cell lung cancer.
Phernambucq EC; Spoelstra FO; Paul MA; Senan S; Melissant CF; Postmus PE; Smit EF
Eur J Cardiothorac Surg; 2009 Dec; 36(6):1052-7. PubMed ID: 19616442
[TBL] [Abstract][Full Text] [Related]
19. Is trimodality approach better then bimodality in stage IIIA, N2 positive non-small cell lung cancer?
Park BB; Park JO; Kim H; Ahn YC; Choi YS; Kim K; Kim J; Shim YM; Ahn JS; Park K
Lung Cancer; 2006 Sep; 53(3):323-30. PubMed ID: 16844258
[TBL] [Abstract][Full Text] [Related]
20. Pathologic response rates following definitive dose image-guided chemoradiotherapy and resection for locally advanced non-small cell lung cancer.
Shumway D; Corbin K; Salgia R; Hoffman P; Villaflor V; Malik RM; Haraf DJ; Vigneswaren WT; Shaikh AY; Connell PP; Ferguson MK; Salama JK
Lung Cancer; 2011 Dec; 74(3):446-50. PubMed ID: 21676484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]